SUN PHARMACEUTICAL INDUSTRIES
Back to Income Statement
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹9,576 Cr | ₹8,474 Cr | ₹3,273 Cr | ₹2,904 Cr | ₹3,765 Cr |
What is the latest Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹9,576 Cr |
| Mar2024 | ₹8,474 Cr |
| Mar2023 | ₹3,273 Cr |
| Mar2022 | ₹2,904 Cr |
| Mar2021 | ₹3,765 Cr |
How is Consolidated Net Profit of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹9,576 Cr | 13.01 | |
| Mar2024 | ₹8,474 Cr | 158.91 | |
| Mar2023 | ₹3,273 Cr | 12.70 | |
| Mar2022 | ₹2,904 Cr | -22.87 | |
| Mar2021 | ₹3,765 Cr | - | |
Compare Consolidated Net Profit of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,872.3 Cr | 1.5% | 6.9% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,620.0 Cr | -0.8% | 1.7% | 14% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,431.0 Cr | 3.2% | 9% | 44.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,070.0 Cr | 1.1% | 5% | 16.4% | Stock Analytics | |
| CIPLA | ₹107,051.0 Cr | 0.3% | -1.3% | -9% | Stock Analytics | |
| MANKIND PHARMA | ₹91,161.8 Cr | 1% | 6.6% | -1.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1.5% |
6.9% |
13.1% |
| SENSEX | -5% |
-9.6% |
3.1% |
You may also like the below Video Courses